申请人:Sorensen Lindy Jan
公开号:US20080113995A1
公开(公告)日:2008-05-15
A novel class of substituted homopiperidine, piperidine and pyrrolidine derivatives, methods for their preparation, pharmaceutical compositions comprising them and use thereof in the treatment of disorders related to the histamine H3 receptor. More particularly, the compounds possess histamine H3 receptor antagonistic activity and are thus useful in the treatment of disorders in which a histamine H3 receptor blockade is beneficial.
一种新型的取代的同源吡啶,吡啶和吡咯烷衍生物,其制备方法,包含它们的药物组合物以及在治疗与组胺H3受体相关的疾病中的使用。更具体地说,这些化合物具有组胺H3受体拮抗活性,因此在需要组胺H3受体阻滞有益的疾病治疗中有用。